CLOV stock · KMTS stock

CLOV vs KMTS · rev $1.37B vs rev $59.8M

Clover Health Investments Corp (CLOV) versus Kestra Medical Technologies, Ltd. Common Stock (KMTS) — a side-by-side from cached financials, not a winner call.

Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.

Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.

Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.

Latest reported KMTS revenue for 2025-04-30 was $59.8M. Net income was -$113.8M. Revenue was up 115.1% from 2024-04-30 to 2025-04-30. KMTS currently screens at market cap $1.24B.

CLOV currently screens at market cap $1.55B. KMTS currently screens at market cap $1.24B.

Not investment advice. Open the CLOV and KMTS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons